Abstract:Two types of cannabinoid receptor have been discovered so far, CB(1) (2.1: CBD:1:CB1:), cloned in 1990, and CB(2) (2.1:CBD:2:CB2:), cloned in 1993. Distinction between these receptors is based on differences in their predicted amino acid sequence, signaling mechanisms, tissue distribution, and sensitivity to certain potent agonists and antagonists that show marked selectivity for one or the other receptor type. Cannabinoid receptors CB(1) and CB(2) exhibit 48% amino acid sequence identity. Both receptor types are coupled through G proteins to adenylyl cyclase and mitogen-activated protein kinase. CB(1) receptors are also coupled through G proteins to several types of calcium and potassium channels. These receptors exist primarily on central and peripheral neurons, one of their functions being to inhibit neurotransmitter release. Indeed, endogenous CB(1) agonists probably serve as retrograde synaptic messengers. CB(2) receptors are present mainly on immune cells. Such cells also express CB(1) receptors, albeit to a lesser extent, with both receptor types exerting a broad spectrum of immune effects that includes modulation of cytokine release. Of several endogenous agonists for cannabinoid receptors identified thus far, the most notable are arachidonoylethanolamide, 2-arachidonoylglycerol, and 2-arachidonylglyceryl ether. It is unclear whether these eicosanoid molecules are the only, or primary, endogenous agonists. Hence, we consider it premature to rename cannabinoid receptors after an endogenous agonist as is recommended by the International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. Although pharmacological evidence for the existence of additional types of cannabinoid receptor is emerging, other kinds of supporting evidence are still lacking.

Cannabinoid Receptor-Related Orphan G Protein-Coupled Receptors

The orphan receptor GPR55 is a novel cannabinoid receptor

A homology modeling study toward the understanding of three-dimensional structure and putative pharmacological profile of the G-protein coupled receptor GPR55.

International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors

GPR55, a Lysophosphatidylinositol Receptor with Cannabinoid Sensitivity?

Structure basis of ligand recognition and activation of GPR55

Orphan G protein-coupled receptors: the ongoing search for a home

G protein-coupled receptor deorphanizations.

Molecular biology of cannabinoid receptors

New Insights in Cannabinoid Receptor Structure and Signaling

Orphan G Protein-Coupled Receptors (gpcrs): Biological Functions and Potential Drug Targets

The current status and prospects of research on orphan G protein-coupled receptor

Neuro-psychopharmacological Perspective of Orphan Receptors of Rhodopsin (class A) Family of G Protein-Coupled Receptors

The G protein-coupled receptors deorphanization landscape

Cannabinoids and Cannabinoid Receptors: The Story so Far

Orphan Receptor GPR88 As an Emerging Neurotherapeutic Target

Computational Investigations on the Binding Mode of Ligands for the Cannabinoid-Activated G Protein-Coupled Receptor GPR18

G Protein–Coupled Receptor (GPCR) Expression in Native Cells: “Novel” endoGPCRs as Physiologic Regulators and Therapeutic Targets

Research Status of the Orphan G Protein Coupled Receptor 158 and Future Perspectives

Cannabinoid Receptor Signal Transduction Pathways

Lipid-Dependent Activation of the Orphan G Protein-Coupled Receptor, GPR3